| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abdel-Wahab N, Tayar JH, Fa'ak F, et al. Systematic review of observational studies reporting antiphospholipid antibodies in patients with solid tumors. Blood Adv. 2020;4(8):1746-1755.
|
|
|
|
4 |
19 |
p. 4605
|
artikel
|
| 2 |
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|
Ortel, Thomas L.
|
|
|
4 |
19 |
p. 4693-4738
|
artikel
|
| 3 |
An induced pluripotent stem cell model of Fanconi anemia reveals mechanisms of p53-driven progenitor cell differentiation
|
Marion, William
|
|
|
4 |
19 |
p. 4679-4692
|
artikel
|
| 4 |
Augmenting emergency granulopoiesis with CpG conditioned mesenchymal stromal cells in murine neutropenic sepsis
|
Ng, Julie
|
|
|
4 |
19 |
p. 4965-4979
|
artikel
|
| 5 |
Axicabtagene ciloleucel for relapsed or refractory lymphoma after prior treatment with a different CD19-directed CAR T-cell therapy
|
Chow, Victor A.
|
|
|
4 |
19 |
p. 4869-4872
|
artikel
|
| 6 |
BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus–associated T/NK-cell lymphoma
|
Sejic, Nenad
|
|
|
4 |
19 |
p. 4775-4787
|
artikel
|
| 7 |
Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients
|
Laribi, Kamel
|
|
|
4 |
19 |
p. 4838-4848
|
artikel
|
| 8 |
BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell–like histiocytosis in immune-deficient mice
|
Rafiei, Anahita
|
|
|
4 |
19 |
p. 4912-4917
|
artikel
|
| 9 |
Busulfan and melphalan conditioning is superior to melphalan alone in autologous stem cell transplantation for high-risk MM
|
Saini, Neeraj
|
|
|
4 |
19 |
p. 4834-4837
|
artikel
|
| 10 |
CD1a is rarely expressed in pediatric or adult relapsed/refractory T-ALL: implications for immunotherapy
|
Leong, Sarah
|
|
|
4 |
19 |
p. 4665-4668
|
artikel
|
| 11 |
Clinical Activity of Axicabtagene Ciloleucel in Adult Patients with Richter Syndrome
|
Kittai, Adam S.
|
|
|
4 |
19 |
p. 4648-4652
|
artikel
|
| 12 |
Comparison of outcomes of HCT in blast phase of BCR-ABL1 − MPN with de novo AML and with AML following MDS
|
Gupta, Vikas
|
|
|
4 |
19 |
p. 4748-4757
|
artikel
|
| 13 |
Diagnosis and treatment of mixed phenotype (T-myeloid/lymphoid) acute leukemia with novel ETV6-FGFR2 rearrangement
|
Carll, Timothy
|
|
|
4 |
19 |
p. 4924-4928
|
artikel
|
| 14 |
Editorial Board
|
|
|
|
4 |
19 |
p. i
|
artikel
|
| 15 |
Fusion partner–specific mutation profiles and KRAS mutations as adverse prognostic factors in MLL-rearranged AML
|
Matsuo, Hidemasa
|
|
|
4 |
19 |
p. 4623-4631
|
artikel
|
| 16 |
HLA-A alleles influencing NK cell function impact AML relapse following allogeneic hematopoietic cell transplantation
|
van der Ploeg, Kattria
|
|
|
4 |
19 |
p. 4955-4964
|
artikel
|
| 17 |
Hodges JR, Phillips SM, Norell S, et al. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. Blood Adv. 2020;4(18):4463-4473.
|
|
|
|
4 |
19 |
p. 4822
|
artikel
|
| 18 |
Human ferroportin mediates proton-coupled active transport of iron
|
Li, Shuang
|
|
|
4 |
19 |
p. 4758-4768
|
artikel
|
| 19 |
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy
|
Davis, Joanne E.
|
|
|
4 |
19 |
p. 4849-4859
|
artikel
|
| 20 |
Inhibitors and Mortality in Persons with Nonsevere Hemophilia A in the United States
|
Lim, Ming Y.
|
|
|
4 |
19 |
p. 4739-4747
|
artikel
|
| 21 |
Inverse relationship between oligoclonal expanded CD69− TTE and CD69+ TTE cells in bone marrow of multiple myeloma patients
|
Vuckovic, Slavica
|
|
|
4 |
19 |
p. 4593-4604
|
artikel
|
| 22 |
Leukemic evolution of polycythemia vera and essential thrombocythemia: genomic profiles predict time to transformation
|
Luque Paz, Damien
|
|
|
4 |
19 |
p. 4887-4897
|
artikel
|
| 23 |
Lingering effects of chemotherapy on mature T cells impair proliferation
|
Das, Rajat K.
|
|
|
4 |
19 |
p. 4653-4664
|
artikel
|
| 24 |
Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
|
Voso, Maria Teresa
|
|
|
4 |
19 |
p. 4945-4954
|
artikel
|
| 25 |
MLL-TFE3: a novel and aggressive KMT2A fusion identified in infant leukemia
|
Kosasih, Hansen J.
|
|
|
4 |
19 |
p. 4918-4923
|
artikel
|
| 26 |
Multiple donor-derived leukemias in a recipient of allogeneic hematopoietic cell transplantation for myeloid malignancy
|
Aldoss, Ibrahim
|
|
|
4 |
19 |
p. 4798-4801
|
artikel
|
| 27 |
Naive T-cell depletion in stem cell transplantation
|
Bleakley, Marie
|
|
|
4 |
19 |
p. 4980
|
artikel
|
| 28 |
Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies
|
Sermer, David
|
|
|
4 |
19 |
p. 4669-4678
|
artikel
|
| 29 |
Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation
|
Yoshifuji, Kota
|
|
|
4 |
19 |
p. 4607-4617
|
artikel
|
| 30 |
Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study
|
Camargo, Jose F.
|
|
|
4 |
19 |
p. 4618-4622
|
artikel
|
| 31 |
Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews
|
Darzi, Andrea J.
|
|
|
4 |
19 |
p. 4929-4944
|
artikel
|
| 32 |
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)
|
Thom, Katharina
|
|
|
4 |
19 |
p. 4632-4639
|
artikel
|
| 33 |
Safety of venetoclax rapid dose escalation in CLL patients previously treated with B-cell receptor signaling antagonists
|
Koenig, Kristin L.
|
|
|
4 |
19 |
p. 4860-4863
|
artikel
|
| 34 |
Successful transfer of anti–SARS-CoV-2 immunity using convalescent plasma in an MM patient with hypogammaglobulinemia and COVID-19
|
Luetkens, Tim
|
|
|
4 |
19 |
p. 4864-4868
|
artikel
|
| 35 |
Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and/or pulmonary presentations
|
Feurstein, Simone
|
|
|
4 |
19 |
p. 4873-4886
|
artikel
|
| 36 |
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma
|
Ghione, Paola
|
|
|
4 |
19 |
p. 4640-4647
|
artikel
|
| 37 |
Thapa B, Caimi PF, Ardeshna KM, et al. CD19 antibody-drug conjugate therapy in DLBCL does not preclude subsequent responses to CD19-directed CAR T-cell therapy. Blood Adv. 2020;4(16):3850-3852.
|
|
|
|
4 |
19 |
p. 4606
|
artikel
|
| 38 |
The synergistic proapoptotic effect of PARP-1 and HDAC inhibition in cutaneous T-cell lymphoma is mediated via Blimp-1
|
Kruglov, Oleg
|
|
|
4 |
19 |
p. 4788-4797
|
artikel
|
| 39 |
The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation
|
Solh, Melhem M.
|
|
|
4 |
19 |
p. 4812-4821
|
artikel
|
| 40 |
TNFR2 is required for RIP1-dependent cell death in human leukemia
|
Aguadé-Gorgorió, Júlia
|
|
|
4 |
19 |
p. 4823-4833
|
artikel
|
| 41 |
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
|
Locke, Frederick L.
|
|
|
4 |
19 |
p. 4898-4911
|
artikel
|
| 42 |
Whole-genome sequencing reveals potent therapeutic strategy for monomorphic epitheliotropic intestinal T-cell lymphoma
|
Huang, Dachuan
|
|
|
4 |
19 |
p. 4769-4774
|
artikel
|
| 43 |
Zanubrutinib (BGB-3111) plus obinutuzumab in patients with chronic lymphocytic leukemia and follicular lymphoma
|
Tam, Constantine S.
|
|
|
4 |
19 |
p. 4802-4811
|
artikel
|
Tijdschrift beschrijving